Metagenomi Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $364.8M
Liabilities Breakdown FY2023
Total Liabilities: $149.7M
Asset Breakdown
Total Assets: $364.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $140.6M | 38.5% |
| Accounts Receivable | $2.5M | 0.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $21.5M | 5.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $200.2M | 54.9% |
Liabilities Breakdown
Total Liabilities: $149.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.8M | 1.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $147.9M | 98.8% |